2026 FDA Status GLP-1 patches are not FDA-approved for weight loss or any medical condition
Both drugs may cause mild but manageable GI side effects , such as nausea, vomiting, and diarrhea
Combined with developments like oral GLP-1s , that could mean a future with millions more people taking them for entirely different reasons
Weight loss on Wegovy varies from person to person, but most people start losing weight after 4 weeks, with significant results taking several months or longer
Increasing BMI has been correlated with higher mortality risks, including a 29% rise in overall mortality and over a 200% increase in diabetes-related mortality for every 5-unit BMI increase above 25 kg/m (4)
Ozempic is only prescribed to type 2 diabetic patients for the sole purpose of glycemic control